Literature DB >> 23397291

Metformin and mortality. Reply to Lund SS [letter].

R J Stevens, B J Cairns, R R Holman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23397291     DOI： 10.1007/s00125-013-2844-x

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  7 in total

1.  The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).

Authors:  A Ramachandran; C Snehalatha; S Mary; B Mukesh; A D Bhaskar; V Vijay
Journal:  Diabetologia       Date:  2006-01-04       Impact factor: 10.122

2.  Metformin and mortality.

Authors:  S S Lund
Journal:  Diabetologia       Date:  2013-02-02       Impact factor: 10.122

3.  Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks.

Authors:  A Pfützner; E Paz-Pacheco; E Allen; R Frederich; R Chen
Journal:  Diabetes Obes Metab       Date:  2011-06       Impact factor: 6.577

Review 4.  Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials.

Authors:  R J Stevens; R Ali; C R Bankhead; M A Bethel; B J Cairns; R P Camisasca; F L Crowe; A J Farmer; S Harrison; J A Hirst; P Home; S E Kahn; J H McLellan; R Perera; A Plüddemann; A Ramachandran; N W Roberts; P W Rose; A Schweizer; G Viberti; R R Holman
Journal:  Diabetologia       Date:  2012-08-10       Impact factor: 10.122

5.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

6.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

7.  Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus.

Authors:  Adriaan Kooy; Jolien de Jager; Philippe Lehert; Daniël Bets; Michiel G Wulffelé; Ab J M Donker; Coen D A Stehouwer
Journal:  Arch Intern Med       Date:  2009-03-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.